Lv63
1724 积分 2024-03-18 加入
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
23天前
已完结
Multiple myeloma
1个月前
已完结
Multiple myeloma
1个月前
已完结
Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence
1个月前
已完结
Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence
1个月前
已完结
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors
2个月前
已完结
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
2个月前
已完结
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
2个月前
已完结
Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors
2个月前
已完结
HLA-independent T cell receptors for targeting tumors with low antigen density
2个月前
已完结
皖公网安备34019202002308
